• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Within-person variability in high-sensitivity C-reactive protein.高敏C反应蛋白的个体内变异性。
Arch Intern Med. 2012 Oct 22;172(19):1519-21. doi: 10.1001/archinternmed.2012.3712.
2
Summaries for patients. C-reactive protein and prediction of risk for cardiovascular disease in women.患者摘要。C反应蛋白与女性心血管疾病风险预测
Ann Intern Med. 2006 Jul 4;145(1):I19. doi: 10.7326/0003-4819-145-1-200607040-00003.
3
High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults.美国成年人的高密度脂蛋白胆固醇、高敏 C 反应蛋白与心血管疾病。
Am J Cardiol. 2012 Nov 15;110(10):1464-7. doi: 10.1016/j.amjcard.2012.06.056. Epub 2012 Aug 2.
4
C-reactive protein for cardiovascular risk assessment.用于心血管风险评估的C反应蛋白
Diabetes Care. 2005 Jul;28(7):1833-4. doi: 10.2337/diacare.28.7.1833-a.
5
Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006).无症状成年人血清 25-羟维生素 D 与 C 反应蛋白的关系（来源于 2001 至 2006 年连续全国健康与营养调查）。
Am J Cardiol. 2012 Jan 15;109(2):226-30. doi: 10.1016/j.amjcard.2011.08.032. Epub 2011 Oct 12.
6
Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.高敏C反应蛋白的六年变化与糖尿病、心血管疾病及死亡风险
Am Heart J. 2015 Aug;170(2):380-9. doi: 10.1016/j.ahj.2015.04.017. Epub 2015 Apr 18.
7
Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?在慢性恰加斯病患者中，五聚素3是一种心血管标志物吗？
Int J Cardiol. 2015;190:233-5. doi: 10.1016/j.ijcard.2015.04.106. Epub 2015 Apr 16.
8
The effect of including C-reactive protein in cardiovascular risk prediction models for women.将C反应蛋白纳入女性心血管疾病风险预测模型的效果。
Ann Intern Med. 2006 Jul 4;145(1):21-9. doi: 10.7326/0003-4819-145-1-200607040-00128.
9
C-reactive protein risk prediction: low specificity, high sensitivity.
Ann Intern Med. 2002 Apr 2;136(7):550-2. doi: 10.7326/0003-4819-136-7-200204020-00014.
10
CRP measurement: does the assay matter in hemodialysis patients?C反应蛋白检测：检测方法对血液透析患者重要吗？
Clin Nephrol. 2008 Dec;70(6):503-7. doi: 10.5414/cnp70503.

引用本文的文献

1
High-sensitivity C-reactive Protein in Atherosclerotic Cardiovascular Disease: To Measure or Not to Measure?动脉粥样硬化性心血管疾病中的高敏C反应蛋白：测还是不测？
US Cardiol. 2025 Mar 21;19:e06. doi: 10.15420/usc.2024.25. eCollection 2025.
2
Do all individuals benefit equally from non-surgical periodontal therapy? Secondary analyses of systematic review data.所有个体从非手术牙周治疗中获得的益处都相同吗？系统评价数据的二次分析。
J Periodontal Res. 2024 Sep 25. doi: 10.1111/jre.13347.
3
Epigenetic scores derived in saliva are associated with gestational age at birth.唾液中提取的表观遗传评分与出生时的胎龄有关。
Clin Epigenetics. 2024 Jun 29;16(1):84. doi: 10.1186/s13148-024-01701-2.
4
High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk.稳定期支气管扩张症患者的高敏 C 反应蛋白水平可预测加重风险。
BMC Pulm Med. 2024 Feb 13;24(1):80. doi: 10.1186/s12890-024-02888-z.
5
Associations between healthy food groups and platelet-activating factor, lipoprotein-associated phospholipase A and C-reactive protein: a cross-sectional study.健康食物组与血小板激活因子、脂蛋白相关磷脂酶 A 和 C 反应蛋白之间的关联：一项横断面研究。
Eur J Nutr. 2024 Mar;63(2):445-460. doi: 10.1007/s00394-023-03277-8. Epub 2023 Dec 8.
6
The association between dietary quality scores with C-reactive protein and novel biomarkers of inflammation platelet-activating factor and lipoprotein-associated phospholipase A2: a cross-sectional study.饮食质量评分与C反应蛋白以及炎症新生物标志物血小板活化因子和脂蛋白相关磷脂酶A2之间的关联：一项横断面研究。
Nutr Metab (Lond). 2023 Sep 12;20(1):38. doi: 10.1186/s12986-023-00756-x.
7
Potential Modulation of Inflammation and Physical Function by Combined Probiotics, Omega-3 Supplementation and Vitamin D Supplementation in Overweight/Obese Patients with Chronic Low-Grade Inflammation: A Randomized, Placebo-Controlled Trial.超重/肥胖合并慢性低度炎症患者中益生菌、ω-3 补充剂和维生素 D 补充剂联合应用对炎症和身体功能的潜在调节作用：一项随机、安慰剂对照试验。
Int J Mol Sci. 2023 May 10;24(10):8567. doi: 10.3390/ijms24108567.
8
Potential Modulation of Inflammation by Probiotic and Omega-3 Supplementation in Elderly with Chronic Low-Grade Inflammation-A Randomized, Placebo-Controlled Trial.益生菌和欧米伽-3 补充剂对慢性低度炎症老年人炎症的潜在调节：一项随机、安慰剂对照试验。
Nutrients. 2022 Sep 27;14(19):3998. doi: 10.3390/nu14193998.
9
Adverse childhood experiences, bullying, inflammation and BMI in 10-year-old children: The biological embodiment.儿童期不良经历、欺凌、炎症与 10 岁儿童 BMI：生物体现。
PLoS One. 2022 Aug 19;17(8):e0273329. doi: 10.1371/journal.pone.0273329. eCollection 2022.
10
Sepsis Related Mortality Associated with an Inflammatory Burst in Patients Admitting to the Department of Internal Medicine with Apparently Normal C-Reactive Protein Concentration.内科收治的C反应蛋白浓度看似正常的患者中，与炎症爆发相关的脓毒症死亡率
J Clin Med. 2022 Jun 1;11(11):3151. doi: 10.3390/jcm11113151.

本文引用的文献

1
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2010年美国心脏病学会基金会/美国心脏协会无症状成年人心血管风险评估指南：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2010 Dec 21;122(25):e584-636. doi: 10.1161/CIR.0b013e3182051b4c. Epub 2010 Nov 15.
2
From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey.从这里到“朱庇特”：利用1999 - 2004年国家健康与营养检查调查的数据识别他汀类药物治疗的新患者
Circ Cardiovasc Qual Outcomes. 2009 Jan;2(1):41-8. doi: 10.1161/CIRCOUTCOMES.108.832592. Epub 2009 Jan 13.
3
Fluctuating inflammatory markers in patients with stable ischemic heart disease.稳定型缺血性心脏病患者炎症标志物的波动情况。
Arch Intern Med. 2005 Jan 24;165(2):221-6. doi: 10.1001/archinte.165.2.221.
4
Inflammation as a cardiovascular risk factor.炎症作为一种心血管危险因素。
Circulation. 2004 Jun 1;109(21 Suppl 1):II2-10. doi: 10.1161/01.CIR.0000129535.04194.38.
5
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.炎症与心血管疾病标志物：在临床及公共卫生实践中的应用：美国疾病控制与预防中心和美国心脏协会给医疗专业人员的声明
Circulation. 2003 Jan 28;107(3):499-511. doi: 10.1161/01.cir.0000052939.59093.45.
6
Clinical application of C-reactive protein for cardiovascular disease detection and prevention.C反应蛋白在心血管疾病检测与预防中的临床应用。
Circulation. 2003 Jan 28;107(3):363-9. doi: 10.1161/01.cir.0000053730.47739.3c.
7
Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.
Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1156-62. doi: 10.1161/01.atv.16.9.1156.
8
Statistical methods for assessing agreement between two methods of clinical measurement.评估两种临床测量方法之间一致性的统计方法。
Lancet. 1986 Feb 8;1(8476):307-10.

Within-person variability in high-sensitivity C-reactive protein.

作者信息

Bower Julie K, Lazo Mariana, Juraschek Stephen P, Selvin Elizabeth

出版信息

Arch Intern Med. 2012 Oct 22;172(19):1519-21. doi: 10.1001/archinternmed.2012.3712.

DOI:10.1001/archinternmed.2012.3712
PMID:22945505
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3613132/
Abstract
摘要